Skip to content

Why Doesn't McDonald's Have Plant-Based Options Nationwide?

3 min read

According to the Good Food Institute, the popularity of meat alternatives in the U.S. declined in 2022 and 2023, a trend that helps explain why McDonald's doesn't have plant-based offerings on its permanent menu nationwide. A failed U.S. test of the McPlant burger, despite its success in other countries, proved that a plant-based option wasn't the right fit for the company's American market at the time.

Quick Summary

Limited consumer demand, operational complexities, and a strategic focus on other menu items, like chicken, led to the discontinuation of the U.S. McPlant trial. In contrast, the McPlant remains a successful permanent menu item in numerous international markets.

Key Points

  • Failed U.S. Trial: A 2022 test of the McPlant burger in select U.S. cities, including San Francisco and Dallas, was unsuccessful due to low sales.

  • Operational Hurdles: The McPlant's limited demand and added kitchen complexity made it an inefficient menu item for McDonald's U.S. operations.

  • Cross-Contamination: Unlike some international versions, the U.S. McPlant was cooked on the same grill as meat, deterring many vegetarians and vegans.

  • Global Success Story: The McPlant remains a successful and permanent menu item in European markets like the UK and Germany, where consumer demand for plant-based foods is higher.

  • Shift to Chicken: Following the failed trial, McDonald's announced it would refocus its investment on its highly profitable and in-demand chicken product lineup in the U.S..

  • Not a Vegan Burger: The U.S. version of the McPlant was not truly vegan by default, as it included mayonnaise and American cheese.

  • Beyond Meat Partnership: The McPlant burger patty was a joint development with plant-based protein company Beyond Meat.

In This Article

The McPlant U.S. Trial and Its Fizzle

In early 2022, McDonald's concluded its U.S. test run of the McPlant burger, a product co-developed with Beyond Meat. The rollout, tested in select markets such as San Francisco and Dallas, yielded disappointing sales results, failing to meet expectations. Despite the burger's permanent menu status and success in European countries like the UK, Germany, and the Netherlands, the U.S. trial ended without plans for a nationwide launch. Joe Erlinger, the president of McDonald's USA, acknowledged the test's lack of success and the current U.S. consumer disinterest in a plant-based burger from the brand.

Factors Contributing to the McPlant's U.S. Failure

Several factors contributed to the McPlant's poor U.S. performance, highlighting difficulties in integrating plant-based items into large-scale fast-food operations.

  • Low Consumer Demand: Unlike some competitors, McDonald's observed a lack of strong U.S. customer demand for a plant-based burger, coinciding with a general decline in the popularity of meat alternatives in the U.S. during the trial.
  • Operational Complexities: Adding a new menu item, particularly one with specific preparation needs, complicates McDonald's streamlined kitchen processes. The McPlant trial likely showed that the added logistical challenge wasn't justified by low sales; some franchisees noted the need for made-to-order cooking, causing delays.
  • Cross-Contamination Concerns: While some international markets cook the McPlant separately, the U.S. trial involved cooking it on the same grill as beef burgers, using shared equipment. This was a deterrent for many vegetarians and vegans.
  • Health and Flavor Perceptions: Some consumers found realistic plant-based alternatives like Beyond Meat too meat-like or perceived them as less healthy. Others felt the flavor and texture didn't match the traditional McDonald's burger.

The Global Contrast: McPlant's Success Overseas

In contrast to the U.S., the McPlant has been successful as a permanent menu item in various international markets. This highlights regional differences in consumer preferences and dining habits.

  • European Consumer Base: The European market, especially in the UK, Germany, and the Netherlands, has a larger flexitarian and vegan consumer base more open to meat-free options.
  • Dedicated Vegan Preparation: In locations like the UK, the McPlant is vegan certified and prepared separately with dedicated utensils, addressing cross-contamination concerns.
  • Localized Menu Strategy: McDonald's tailors its menu to regional tastes. The McPlant platform, offering various plant-based options, has been a better fit for European preferences.

The Strategic Shift: From Plant-Based to Chicken

Following the unsuccessful U.S. McPlant trial, McDonald's announced a strategic pivot to invest heavily in its chicken products, citing internal data indicating chicken as a significant growth area. Joe Erlinger noted chicken's larger protein consumption trend, positioning McDonald's to serve this market. This business-focused strategy prioritizes investments in categories with high consumer demand and profitability over niche markets. While future plant-based options aren't entirely ruled out, they are not a U.S. market priority currently.

Comparison of McPlant Performance (U.S. vs. Europe)

Feature U.S. Market (Trial) European Market (Permanent)
Availability Limited test run in 600 restaurants across select cities. Permanent menu item in the UK, Germany, Netherlands, etc..
Sales Performance Slow sales and low consumer demand led to discontinuation. Strong, market-leading sales, praised by customer groups.
Preparation Cooked on the same grill as meat products, creating cross-contamination issues. Cooked separately with dedicated utensils, ensuring vegan certification.
Certification Not fully vegan due to dairy cheese and mayo options. Vegan certified in multiple countries, with vegan sauce and cheese alternatives.
Strategic Priority Lower priority; company shifted focus to growing chicken category. Higher priority, part of a commitment to expanding market-leading vegan offerings.

Conclusion

Ultimately, why doesn't McDonald's have plant-based products nationally in the U.S. comes down to a failed market test. Despite partnering with Beyond Meat and achieving success internationally, the McPlant didn't resonate with U.S. consumers who favored traditional options. Operational issues, potential cross-contamination, and evolving consumer trends also played a role. While plant-based items are part of the strategy elsewhere, McDonald's has determined that the American market isn't currently ready for its meat-free alternatives. The company's focus on its profitable chicken category demonstrates its data-driven, demand-centric business approach.

Further Reading

Frequently Asked Questions

No, the McPlant burger is not currently available in the U.S. A trial run conducted in 2022 was ended due to low consumer demand and poor sales performance.

The difference in success can be attributed to regional consumer demand, operational challenges, and preparation methods. European markets have shown greater demand for plant-based options, and their McPlant is prepared separately from meat to avoid cross-contamination, a key concern for U.S. consumers.

No, McDonald's french fries in the U.S. are not vegan. They contain a "natural beef flavoring," which includes milk, making them unsuitable for those on a vegan or strict vegetarian diet.

U.S. vegan options are very limited and may vary by location. The Baked Apple Pie is vegan, as are apple slices. Other options are limited to modifying standard items, such as ordering a burger bun with condiments but no patty.

McDonald's is focusing on its chicken category because it is a much larger and faster-growing segment with significantly higher consumer demand in the U.S. compared to plant-based items.

McDonald's hasn't ruled it out completely but has stated that it has no immediate plans to reintroduce a plant-based burger in the U.S. The company will continue to monitor consumer trends.

The McPlant patty was co-developed with Beyond Meat and is made from ingredients like peas, rice, and potatoes.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.